FDA 483 - RemedyRepack Inc. - April 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
RemedyRePack Inc., a drug repacker and relabeler in Indiana, PA, received seven observations during an FDA inspection from April 8-14, 2025. The firm was cited for significant deficiencies in its quality control and production processes, including a repeat observation regarding packaging process validation. Key issues include inadequate written procedures for critical operations, poor labeling controls, and failure to maintain equipment cleanliness and proper drug storage conditions.
ID · 4bbf7849-d81d-4d6b-8179-f9b9ba3293dc